Broese Johanna Mc, de Heij Albert H, Janssen Daisy Ja, Skora Julia A, Kerstjens Huib Am, Chavannes Niels H, Engels Yvonne, van der Kleij Rianne Mjj
Public Health & Primary care, Leiden University Medical Centre, Leiden, The Netherlands.
Lung Alliance Netherlands, The Netherlands.
Palliat Med. 2021 Mar;35(3):486-502. doi: 10.1177/0269216320981294. Epub 2020 Dec 18.
Although guidelines recommend palliative care for patients with chronic obstructive pulmonary disease, there is little evidence for the effectiveness of palliative care interventions for this patient group specifically.
To describe the characteristics of palliative care interventions for patients with COPD and their informal caregivers and review the available evidence on effectiveness and implementation outcomes.
Systematic review and narrative synthesis (PROSPERO CRD42017079962).
Seven databases were searched for articles reporting on multi-component palliative care interventions for study populations containing ⩾30% patients with COPD. Quantitative as well as qualitative and mixed-method studies were included. Intervention characteristics, effect outcomes, implementation outcomes and barriers and facilitators for successful implementation were extracted and synthesized qualitatively.
Thirty-one articles reporting on twenty unique interventions were included. Only four interventions (20%) were evaluated in an adequately powered controlled trial. Most interventions comprised of longitudinal palliative care, including care coordination and comprehensive needs assessments. Results on effectiveness were mixed and inconclusive. The feasibility level varied and was context-dependent. Acceptability of the interventions was high; having someone to call for support and education about breathlessness were most valued characteristics. Most frequently named barriers were uncertainty about the timing of referral due to the unpredictable disease trajectory (referrers), time availability (providers) and accessibility (patients).
Little high-quality evidence is yet available on the effectiveness and implementation of palliative care interventions for patients with COPD. There is a need for well-conducted effectiveness studies and adequate process evaluations using standardized methodologies to create higher-level evidence and inform successful implementation.
尽管指南推荐为慢性阻塞性肺疾病患者提供姑息治疗,但针对这一特定患者群体的姑息治疗干预措施的有效性证据很少。
描述慢性阻塞性肺疾病患者及其非正式照护者的姑息治疗干预措施的特征,并综述关于有效性和实施结果的现有证据。
系统评价和叙述性综合分析(国际前瞻性系统评价注册库编号CRD42017079962)。
检索了七个数据库,以查找有关针对慢性阻塞性肺疾病患者比例≥30%的研究人群的多组分姑息治疗干预措施的文章。纳入了定量研究以及定性和混合方法研究。定性提取并综合了干预措施的特征、效果结果、实施结果以及成功实施的障碍和促进因素。
纳入了31篇报告20种独特干预措施的文章。只有四项干预措施(20%)在一项有足够样本量的对照试验中进行了评估。大多数干预措施包括纵向姑息治疗,包括护理协调和全面需求评估。关于有效性的结果喜忧参半且尚无定论。可行性水平各不相同,且取决于具体情况。干预措施的可接受性很高;有可以寻求支持的人和关于呼吸困难的教育是最受重视的特征。最常提到的障碍是由于疾病轨迹不可预测导致转诊时机不确定(转诊者)、时间可用性(提供者)和可及性(患者)。
关于慢性阻塞性肺疾病患者姑息治疗干预措施的有效性和实施,目前几乎没有高质量的证据。需要进行精心设计的有效性研究和使用标准化方法进行充分的过程评估,以创造更高级别的证据并为成功实施提供依据。